Diagnosing and predicting refractory epilepsy

Acta Neurologica Scandinavica, Supplement

Volumn 112, Issue 181, 2005, Pages 36-39

  Brodie, Martin J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Antiepileptic drugs; Diagnosis; Epilepsy; Prognosis; Refractory; Seizures

Indexed keywords

ANTICONVULSIVE AGENT;

COMORBIDITY; CONFERENCE PAPER; DISEASE SEVERITY; DRUG TOLERABILITY; EPILEPSY; EXPERIENCE; FAMILY HISTORY; HIGH RISK PATIENT; HUMAN; PATIENT REFERRAL; PREDICTION; PROGNOSIS; QUALITY OF LIFE; REMISSION; ANTICONVULSANT THERAPY; ARTICLE; DISABILITY; DISEASE CLASSIFICATION; DISEASE CONTROL; DRUG HYPERSENSITIVITY; EARLY DIAGNOSIS; FEBRILE CONVULSION; IDIOSYNCRATIC REACTION; MEDICAL SPECIALIST; MENTAL DISEASE; MONOTHERAPY; RASH; SEIZURE; SUDDEN DEATH; TREATMENT FAILURE; PSYCHOSURGERY; RISK FACTOR;

ANTICONVULSANTS; COMORBIDITY; EPILEPSY; HUMANS; PROGNOSIS; PSYCHOSURGERY; RISK FACTORS; TREATMENT FAILURE;

EID: 28044459666     PISSN: 00651427     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. ANNEGERS JF, HAUSER WA, ELVEBACK LR. Remission of seizures and relapse in patients with epilepsy. Epilepsia 1979;20:729-37.
2. COCKERELL OC, JOHNSON AL, SANDER JWAS, HART YM, SHORVON SD. Remission of epilepsy: results from the national general practice study of epilepsy. Lancet 1995;346:140-4.
3. KWAN P, BRODIE MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-9.
4. MATTSON JH, CRAMER JA, COLLINS JF. Prognosis for total control of complex partial and secondary generalised tonic-clonic seizures. Neurology 1996;47:68-76.
5. KWAN P, BRODIE MJ. Refractory epilepsy: a progressive, intractable but preventable condition? Seizure 2002;11:77-84.
6. SILLANPÄÄ M, JALAVA M, KALEVA O, SHINNAR S. Long-term prognosis of seizures with onset in childhood. N Engl J Med 1998;338:1715-22.
7. KWAN P, BRODIE MJ. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 2001;357:216-22.
8. CRAMER JA. Quality of life for people with epilepsy. Neurol Clin 1994;12:1-13.
9. DEVINSKY O. Patients with refractory seizures. N Engl J Med 1999;340:1565-70.
10. NILSSON L, AHLBOM A, FARAHMAND BY, ASBERG M, TOMSON T. Risk factors for suicide in epilepsy: a case-control study. Epilepsia 2002;43:644-51.
11. NILSSON L, FARAHMAND BY, PERSSON PG, THIBLIN I, TOMSON T. Risk factors for sudden unexpected death in epilepsy: a case-control study. Lancet 1999;353:888-93.
12. PEDLEY TA, HAUSER WA. Sudden death in epilepsy: a wake-up call for management. Lancet 2002;359:1790-1.
13. MELDRUM BS. Why and when are seizures bad for the brain? Trends Pharmacol Sci 2001;22:445-6.
14. KWAN P, BRODIE MJ. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy. Epilepsia 2005;46:224-35.
15. TREVATHAN E, GILLIAM F. Lost years. Delayed referral for surgically treatable epilepsy. Neurology 2003;61:432-3.
16. WIESE S, BLUME WT, GIRVIN JP, ELIASZIW M. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med 2001;345:311-8.
17. THEODORE WH, FISHER RS. Brain stimulation for epilepsy. Lancet Neurol 2004;3:111-8.
18. COLLABORATIVE GROUP FOR THE STUDY OF EPILEPSY. Prognosis of epilepsy in newly referred patients: a multicenter prospective study of the effects of monotherapy on the long-term course of epilepsy. Epilepsia 1992;33:45-51.
19. SILLANPÄÄ M. Remission of seizures and predictors of intractability in long-term follow-up. Epilepsia 1993;34:930-6.
20. SHORVON SD. The epidemiology and treatment of chronic and refractory epilepsy. Epilepsia 1996;37(Suppl. 2):S1-3.
21. PERUCCA E. Pharmacoresistance in epilepsy: how should it be defined? CNS Drugs 1998;10:171-9.
22. DLUGOS DJ, SAMMEL MD, STROM BL, FARRAR JT. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology 2001;57:2259-64.
23. BERG AT, LEVY SR, NOVOTNY EJ, SHINNAR S. Predictors of intractable epilepsy in childhood: a case-control study. Epilepsia 1996;37:24-30.
24. SEMAH F, PICOT M-C, ADAM C et al. Is the underlying cause of epilepsy a major prognostic factor for recurrence? Neurology 1998;51:1256-62.
25. BRODIE MJ. Glasgow outcome studies. Epilepsy Res 2004;60:96-7.
26. BRODIE MJ, FRENCH JA. Management of epilepsy in adolescents and adults. Lancet 2000;356:323-9.
27. BRODIE MJ, KWAN P. The star systems. Overview and use in determining antiepileptic drug choice. CNS Drugs 2001;15:1-12.
28. KWAN P, BRODIE MJ. Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology 2003;60(Suppl 4):S2-S12.
29. DECKERS CLP, CZUCZWAR SJ, HEKSTER YA et al. Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed. Epilepsia 2000;41:1364-74.
30. BRODIE MJ. Medical therapy of epilepsy: when to initiate treatment and when to combine? J Neurol 2005;252:125-30.